ArticleBMC infectious diseases2025
Mycobacterium farcinogenes-induced lymphadenitis in a pediatric patient: a case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Feline Cutaneous Mycobacteriosis Caused byAnimals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMycobacterium farcinogenes is primarily associated with bovine farcy and rarely infects humans. This report presents the first documented case of a 6-year-old girl diagnosed with lymphadenitis caused by Mycobacterium farcinogenes, resulting from a left submandibular mass. The case highlights the importance of maintaining vigilance for such infections, even in immunocompetent children. CASE PRESENTATION: A 6-year-old girl was hospitalized with a complaint of a “left submandibular mass for nearly 3 months.” Surgical biopsy and subsequent tissue culture confirmed the presence of Mycobacterium farcinogenes. Postoperatively, the patient was treated with a combination of clarithromycin and rifampicin, leading to substantial symptom resolution. She was discharged in stable condition 10 days after surgery. Following discharge, the patient continued the antibiotic regimen for an additional 6 months, with long-term follow-up at 9 months confirming sustained remission without recurrence.
conclusionThis is the first report documenting the isolation of Mycobacterium farcinogenes from the pus of a child with lymphadenitis. The findings suggest that Mycobacterium farcinogenes should be recognized as a possible causative agent of skin and lymph node infections, even in children with intact immune systems. Successful treatment requires thorough surgical debridement accompanied by long-term targeted antibiotic therapy, which proved effective in this case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.